echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Rheumatoid arthritis: Eating the right foods can also relieve joint pain? Research Express

    Rheumatoid arthritis: Eating the right foods can also relieve joint pain? Research Express

    • Last Update: 2022-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yimaitong edited and arranged, please do not reprint
    without authorization.


    New studies1 have shown that simultaneous intake of a potassium-rich diet and new potassium-rich food supplements can significantly reduce joint pain in patients with rheumatoid arthritis (RA), and oral potassium supplementation is safe and effective
    as an adjunct to RA.
    The WHO Guidelines for Potassium Intake in Adults and Children2 recommend that adults should consume more potassium from food in order to reduce blood pressure and the risk of cardiovascular disease, stroke and coronary heart disease, and conditionally recommend a potassium intake of at least 3510 mg/day
    for adults.
    The Recommended Dietary Reference Intakes of Chinese Residents3 is 2000mg/d
    for adults.
    Most foods contain potassium, but legumes, vegetables and fruits are the best sources of potassium, and potassium-rich foods include soybeans, mushrooms, bamboo shoots, seaweed, etc
    .


    Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that suffers from poor
    quality of life.
    Potassium is an essential trace element whose role in RA remains unclear
    .
    A recent food survey on RA reported lower potassium intake in patients with RA
    .
    To explore the effects of oral potassium supplementation in the adjuvant therapy of RA, Indian researchers conducted a randomized controlled trial, which was recently published in the journal medRxiv.


    Study design


    This review was a randomized, single-blind (evaluator), validly controlled, parallel-efficacy, 16-week trial involving 172 adult patients with RA (according to the 1987 ACR diagnostic criteria) with a disease duration of ≥ 6 months, divided into 3 treatment groups
    .
    Group A (n=57) consumed a potassium-rich diet, group B (n=57) consumed a potassium-rich diet and potassium-rich food supplements, and group C (n=58) was the control group, and the patients consumed daily diet
    .
    Participants continued to receive RA medication
    during the study.
    Choose from 4 types of foods (vegetables, fruits, legumes and cereals) with no fasting and no intake of any other kind of food, 3 times
    a day.
    Guided by India's Recommended Daily Intake (RDA), a potassium-rich diet provides at least 3500mg/d of potassium
    .
    Potassium-rich food supplements provide 1700-2000mg/d of potassium
    .


    In terms of efficacy, the primary endpoint was the Pain Visual Analogue Score (VAS).

    Secondary endpoints were 66/68 joint swelling and pain/tenderness, revised Stanford Health Assessment Questionnaire (HAQ), ESR, etc
    .
    Assess security
    .
    Urine potassium and serum cortisol
    are measured.
    Efficacy and safety were assessed every 4 weeks, with a follow-up of 16 weeks
    .
    Analyze data
    using chi-square tests, for example.


    Research results


    At baseline, the average daily potassium intake of patients in all groups was less than 2750 mg
    .
    The results of 16 weeks showed that the daily potassium intake of patients in group A and B increased, among which the daily potassium intake of group B increased by more than 3 times compared with baseline (5708.
    5mg vs.
    1863.
    7mg), and all patients reached potassium RDA values
    .
    Potassium intake was ≥ 5000mg/day
    for 46% of patients in group A, 84% in group B, and 30% in group C.


    efficacy


    The 16-week results showed a reduction in pain symptoms in all groups (Figure 1), and the mean change in pain VAS was significantly different from baseline (p=0.
    039).

    Among them, the mean change in pain VAS in group B (-2.
    33, 95% confidence interval [CI] -2.
    99, -1.
    48) was significantly better than group A (-1.
    31, 95% CI -2.
    19, -0.
    43, p=0.
    02) and group C (-1.
    25, 95% CI -2.
    03, -0.
    46, p=0.
    04).

    Fig.
    1 Changes in average pain VAS in each group


    The number of joint pain, HAQ score, general health and ESR of 68 patients in each group were improved, and the improvement of group B patients was more obvious
    than that of group A and group C.


    Safety and tolerability


    Group A reported 14 AE cases, Group B reported 16 cases, and Group C reported 11 cases
    .
    AEs are mostly mild, mainly manifested as symptoms related to abdominal discomfort, and no severe AEs
    occur.
    Laboratory tests (CBC, liver and kidney function, potassium) are within the normal range
    .
    None of the ECGs showed any potassium-related abnormalities
    .


    In addition, laboratory test results showed that there was no significant difference in urine potassium levels among the patients, and serum cortisol levels increased, with the most significant
    increase in group B.
    There was a significant but modest negative correlation between potassium intake and VAS (r=-0.
    19).

    Univariate analysis showed that potassium intake ≥ 5000 mg/day (odds ratio [OR] 3.
    14) was significantly associated
    with a low pain VAS score (≤4 cm).


    Research conclusions and discussions


    The results of this study showed that during the 16-week trial period, potassium-rich diet and new potassium-rich food supplements (group B) significantly reduced joint pain in patients with RA compared with intake of potassium-rich diet (group A) or daily diet (group C), and pain VAS scores were significantly different between groups (p=0.
    039).

    Group B had more significant
    improvements in the number of pains, HAQ scores, general health, and ESR in 68 joints compared with Group A and Group C.
    There was no significant difference in AE between groups (p=0.
    67).

    The results suggest that oral potassium supplementation is safe and effective
    as an adjuvant therapy for patients with RA.


    Potassium is beneficial
    for bone health, cardiovascular function, and blood pressure control.
    Diet is the preferred source of potassium supplementation, and the Dietary Reference Intakes for Chinese Residents3 recommends a potassium intake of 2000mg/d for adults, and the WHO Guidelines for Potassium Intake in Adults and Children2 conditionally recommend a potassium intake of at least 3510mg/d
    for adults.
    Due to safety concerns, the potassium content of food supplements is limited, and CAC/GL 55-2005 Codex Alimentarius Guidelines for Vitamins and Minerals for Food Supplements4 recommends that food supplements containing vitamins and minerals should contain at least 15%
    of the FAO/WHO recommended daily intake for each vitamin and/or mineral.
    When determining the maximum intake, in addition to safety factors, the intake of vitamins and minerals obtained from other diets, the reference intake
    of the population should be properly considered.
    The authors believe that further research is needed to revise current recommendations/guidelines
    for potassium intake.


    Studies have confirmed that the efficacy and safety of potassium are related
    to the non-chloride form of potassium in vegetables and fruits.
    Most foods contain potassium, but legumes, vegetables, and fruits are the best sources of potassium5
    .
    According to the "Chinese Encyclopedia of Nutritional Science", every 100g of cereals contains about 100-200mg of potassium, 600-800mg of beans, 200-500mg of vegetables and fruits, about 150-300mg of meat, and 200-300mg
    of fish.
    Foods with potassium content higher than 800mg per 100g of food include soybeans, broad beans, red beans, peas, mushrooms, bamboo shoots, seaweed, etc
    .
    Table 1 shows the potassium content in common foods6
    .


    Table 1 Potassium content in common foods (mg/100g)


    The mechanism of potassium in reducing pain is unclear, and researchers speculate that increased potassium intake can cause an increase in endogenous steroids, thereby reducing pain and inflammation, and it has been reported that modulating potassium channels can control pain and immune-mediated inflammation and needs to be further studied
    .


    References:

    1.
    Toktam Kianifard, Manjit Saluja, Sanjeev Sarmukaddam.
    Adjunct Therapeutic Role of Potassium in Rheumatoid Arthritis : A Randomized Controlled Trial with Suitable Diet and Novel Food Supplement in Symptomatic Patients on Standard Rheumatology Care.
    medRxiv.
    2022.
    06.
    24.
    22276843; doi:https://doi.
    org/10.
    1101/2022.
    06.
    24.
    22276843

    2.
    WHO Potassium Intake for Adults and Children

    3.
    Cheng Yiyong.
    Introduction to the 2013 revised edition of Dietary Reference Intakes for Chinese residents[J].
    Acta Nutica Sinica, 2014, 36(04): 313-317.
    DOI:10.
    13325/j.
    cnki.
    acta.
    nutr.
    sin.
    2014.
    04.
    002

    4.
    CAC/GL 55-2005 Codex Alimentarius Guidelines for Food Supplements with Vitamins and Minerals

    5.
    Ge Keyou.
    Chinese Encyclopedia of Nutritional Science[M].
    People's Medical Publishing House, 2004: 121

    6.
    YANG Yuexin, GE Keyou.
    Chinese Encyclopedia of Nutrition Science(2nd Edition)[M].
    People's Medical Publishing House, 2020: 354

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.